Conjugated Nonionic Detergent Micelles: An Efficient Purification Platform for Dimeric Human Immunoglobulin A.

Area of Science:

• Immunology
• Biochemistry
• Protein Chemistry

Background:

• SARS-COV-2 causes inflammatory respiratory disease, driving research into IgA antibody therapies.
• Galactose-deficient IgA1 polymerization leads to IgA nephropathy, a major cause of kidney failure.
• Existing IgA purification methods may be inefficient or costly for therapeutic development.

Purpose of the Study:

• To develop an efficient, economical, and scalable method for purifying IgA1-IgA2 dimers.
• To characterize the purity and structural integrity of purified IgA dimers.
• To support the development of IgA-based therapies and research into IgA nephropathy.

Main Methods:

• Utilized conjugated nonionic surfactant micellar aggregates (Brij-O20) for IgA purification.
• Employed quantitative capture at pH 7 and extraction at pH 6.5 to maintain antibody integrity.
• Assessed process yields, purity, and structural preservation of recovered IgA dimers.

Main Results:

• Achieved high process yields (88-91%) and purity (94%) using Brij-O20 aggregates.
• Demonstrated that purified IgA dimers retain native secondary structure and do not self-associate.
• Confirmed that increasing reaction volume minimally affects yield or purity.

Conclusions:

• The developed IgA purification protocol is efficient, inexpensive, and scalable.
• This method facilitates pharmaceutical development of IgA-based treatments.
• The protocol enhances understanding of IgA1 polymerization and its role in kidney disease.